Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Small Fiber Neuropathy Due to TS-HDS, FGFR-3, or Plexin D1 Antibodies
NCT04153422Phase 2Recruiting
- Sponsor
- Endeavor Health
- Start
- Dec 2023
- Primary completion
- Aug 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in small fiber neuropathy (SFN), sponsored by Endeavor Health. Started Dec 2023; status: recruiting.
02
Drugs
intravenous immunoglobulin G
03
Conditions
small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT04153422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04153422.